医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.

广告
第一作者: Reid W,Merryman
第一单位: Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, USA. Reid_merryman@dfci.harvard.edu.
作者单位: Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, USA. Reid_merryman@dfci.harvard.edu. [1] Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA. [2] Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, USA. [3] Hematology, Yale University School of Medicine, New Haven, CT, USA. [4] Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA. [5] Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA. [6] Department of Medicine, Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO, USA. [7] Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA. [8] Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. [9] Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. [10] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. [11]
DOI 10.1007/s00277-023-05475-0
PMID 37851072
发布时间 2024-01-06
提交
  • 浏览2
Annals of hematology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷